The Patent Finder

Terms ending in 2032

Osiris Therapeutics, Inc.

Every in-force patent on Osiris Therapeutics, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,637,004Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
In force
 · High confidence
Mesoblast International SàrlIn forceHigh confidence
US 10,258,650Methods of Manufacture of Immunocompatible Chorionic Membrane Products
In force
 · High confidence
Osiris Therapeutics, Inc.In forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Osiris Therapeutics, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited